Digestive Diseases and Sciences

, Volume 56, Issue 9, pp 2631–2638 | Cite as

The Rate of Post-Polypectomy Bleeding for Patients on Uninterrupted Clopidogrel Therapy During Elective Colonoscopy Is Acceptably Low

  • Linda A. Feagins
  • Fatema S. Uddin
  • Raquel E. Davila
  • William V. Harford
  • Stuart J. Spechler
Original Article
First Online:
Received:
Accepted:

Abstract

Background

We do not routinely discontinue clopidogrel before colonoscopy because we have judged the cardiovascular risks of that practice to exceed the risks of post-polypectomy bleeding (PPB).

Aims

The aim of this study was to compare the rates of PPB for clopidogrel users and non-users.

Methods

We performed a retrospective, case–control study of patients who had colonoscopic polypectomy at our VA hospital from July 2008 through December 2009. We compared the frequency of delayed PPB (within 30 days) for patients on uninterrupted clopidogrel therapy with patients not taking clopidogrel. To minimize confounding from differences between groups in conditions that might contribute to PPB, propensity scoring was used to match clopidogrel users with controls based on numerous factors including age, aspirin use, number and size of polyps removed.

Results

A total of 1,967 patients had polypectomy during the study period; 118 were on clopidogrel and 1,849 were not. Logistic regression analysis revealed no significant difference in frequency of PPB between clopidogrel users and non-users (0.8% vs. 0.3%, P = 0.37, unadjusted OR = 2.63, 95% CI 0.31–22). Matched analyses using propensity scoring also revealed no significant difference in PPB rates between clopidogrel users and non-users (0.9% vs. 0%, P = 0.99).

Conclusions

The delayed PPB rate for our patients on clopidogrel was less than 1%, and PPB rates did not differ significantly between users and non-users. Our conclusions are limited by differences in therapeutic methodology between the groups, and our findings are most applicable to small polyps (<1 cm). We speculate that cardiovascular risks of routinely discontinuing clopidogrel before elective colonoscopy may exceed any excess risk of PPB.

Keywords

Polypectomy Thienopyridines Clopidogrel Post-polypectomy bleed 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This study was supported by the Office of Medical Research, Department of Veteran’s Affairs, Dallas, TX (L. A. Feagins) and the Harris Methodist Health Foundation, Dr. Clark R. Gregg Fund (L. A. Feagins).

References

  1. 1.
    Nakajima H, Takami H, Yamagata K, Kariya K, Tamai Y, Nara H. Aspirin effects on colonic mucosal bleeding: implications for colonic biopsy and polypectomy. Dis Colon Rectum. 1997;40:1484–1488.PubMedCrossRefGoogle Scholar
  2. 2.
    Basson MD, Panzini L, Palmer RH. Effect of nabumetone and aspirin on colonic mucosal bleeding time. Aliment Pharmacol Ther. 2001;15:539–542.PubMedCrossRefGoogle Scholar
  3. 3.
    Timothy SK, Hicks TC, Opelka FG, Timmcke AE, Beck DE. Colonoscopy in the patient requiring anticoagulation. Dis Colon Rectum. 2001;44:1845–1848.PubMedCrossRefGoogle Scholar
  4. 4.
    Yousfi M, Gostout CJ, Barron TH, et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol. 2004;99:1785–1789.PubMedCrossRefGoogle Scholar
  5. 5.
    Anderson MA, Ben-Menachem T, Gan SI, et al. [ASGE Standards of Practice Committee] Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009;70:1060–1070.PubMedCrossRefGoogle Scholar
  6. 6.
    Singh M, Mehta N, Murthy UK, et al. Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy. Gastrointest Endosc. 2010;71:998–1005.PubMedCrossRefGoogle Scholar
  7. 7.
    Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008;299:532–539.PubMedCrossRefGoogle Scholar
  8. 8.
    American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society; 2008.Google Scholar
  9. 9.
    Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130.PubMedCrossRefGoogle Scholar
  10. 10.
    van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis. J Am Coll Cadiol. 2009;53:1399–1409.CrossRefGoogle Scholar
  11. 11.
    Kim HS, Kim TI, Kim WH, et al. Risk factors for immediate postpolypectomy bleeding of the colon: a multicenter study. Am J Gastroenterol. 2006;101:1333–1341.PubMedCrossRefGoogle Scholar
  12. 12.
    Sawhney MS, Salfiti N, Nelson DB, Lederle FA, Bond JH. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy. 2008;40:115–119.PubMedCrossRefGoogle Scholar
  13. 13.
    Veitch AM, Baglin TP, Gershlick AH, Harnden SM, Tighe R, Cairns S. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. 2008;57:1322–1329.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC (Outside the USA) 2011

Authors and Affiliations

  • Linda A. Feagins
    • 1
    • 2
    • 3
  • Fatema S. Uddin
    • 1
    • 2
  • Raquel E. Davila
    • 1
    • 2
  • William V. Harford
    • 1
    • 2
  • Stuart J. Spechler
    • 1
    • 2
  1. 1.VA North Texas Healthcare SystemDallasUSA
  2. 2.University of Texas Southwestern Medical CenterDallasUSA
  3. 3.Division of Gastroenterology (111B1)Dallas VA Medical CenterDallasUSA

Personalised recommendations